Immune checkpoint molecules, such as programmed cell death-1 (PD-1) and PD-L1, allow cancer cells to proliferate by inhibiting cytolytic T cell (CTL) and natural killer (NK) cell activity [77,78]. Here, CD274 is linked to cancer.